Status:
UNKNOWN
Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
Lead Sponsor:
National Cancer Centre, Singapore
Conditions:
Retroperitoneal Sarcoma
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Retroperitoneal sarcoma is a rare cancer that accounts for 15% of soft tissue sarcomas and affects many young people. In approximately 50% of patients, the tumour will reappear in the same area regard...
Eligibility Criteria
Inclusion
- Disease Characteristics
- Histologically proven soft tissue sarcoma of one of following high-risk groups:
- Tumours with grade 2 or 3 histology
- Size more than or equal to 5cm
- Extracompartmental and deep extension
- Local recurrence of primary tumour
- Inadequate surgical excision of previously operated on tumour
- Proven diagnosis of recurrent retroperitoneal sarcoma confirmed by imaging modality and/ or intraoperative biopsy
- Patient Characteristics
- Age: ≥21 years old
- Performance status: ECOG 0-1
- Normal haematological, hepatic, coagulation, renal and electrolyte profiles
- Normal left ventricular ejection fraction
- Not pregnant or nursing
Exclusion
- Patient is medically unfit for surgery due to concurrent medical comorbidities.
- Any medical or psychiatric condition(s) which would preclude informed consent.
- Patient is pregnant or nursing.
Key Trial Info
Start Date :
July 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03792867
Start Date
July 23 2018
End Date
March 31 2024
Last Update
October 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Centre Singapore
Singapore, Singapore, 169610